Beta Drugs Market Cap

Beta Drugs has a market cap or net worth of 13.15 billion as of April 29, 2026. Its market cap has decreased by -31.34% in one year.

Market Cap

13.15B

Enterprise Value

13.38B

Revenue

3.85B

Ranking

n/a

PE Ratio

32.93

Stock Price

1,305.30

Market Cap Chart

Since October 25, 2017, Beta Drugs's market cap has increased from 915.98M to 13.15B, an increase of 1,335.20%. That is a compound annual growth rate of 36.74%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	13.15B	-15.93%
Dec 31, 2025	15.64B	-19.04%
Dec 31, 2024	19.31B	36.67%
Dec 29, 2023	14.13B	107.04%
Dec 30, 2022	6.83B	10.89%
Dec 31, 2021	6.16B	497.76%
Dec 31, 2020	Pro	Pro
Dec 27, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jagsonpal Pharmaceuticals	13.67B
Sakar Healthcare	13.93B
Ind-Swift Laboratories	11.65B
Windlas Biotech	18.29B
Indoco Remedies	19.29B
Sigachi Industries	8.04B
Solara Active Pharma Sciences	23.28B
Orchid Pharma	29.68B

Market Cap Rankings